Hypertrophic Cardiomyopathy (HCM) is a genetic heart condition characterized by the thickening of the heart muscle, particularly the left ventricle. This thickening can impede the heart's ability to efficiently pump blood. HCM is often hereditary, and individuals with a family history of the condition are at an increased risk. While some people with HCM may experience no symptoms, others may suffer from chest pain, shortness of breath, or fatigue. In severe cases, HCM can lead to abnormal heart rhythms and an increased risk of sudden cardiac arrest. Diagnosis typically involves a combination of medical history, physical examinations, and diagnostic tests such as echocardiograms. Treatment options aim to alleviate symptoms and may include medications, lifestyle modifications, or, in extreme cases, surgical procedures. Regular monitoring and follow-up with healthcare providers are crucial for managing HCM and preventing complications.
Title : Novel mechanisms and new therapeutics for right heart failure in pulmonary hypertension
Yong Xiao Wang, Albany Medical College, United States
Title : Movement is medicine
Steve Cohen, Medvesta Hypnosis Healthcare, United States
Title : Historical evolution from OPCAB to MIDCAB to mini OPCAB surgical technique and results
Federico Benetti, Benetti Foundation, Argentina
Title : Fats of life, the skinny on novel lipid therapies beyond statins
Ahdy Wadie Helmy, Indiana University School of Medicine, United States
Title : Novel ways of cardiovascular risk assessment
Syed Raza, Awali Hospital, Bahrain
Title : Cardiovascular nanomedicine: Stopping strokes, unclogging arteries and restoring heart function
Thomas J Webster, Hebei University of Technology, China